Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MTHFD2 |
| Upstream (Parents) |
|---|
| (<<) CKS2 → MTHFD2 |
| (<<) ASNS → MTHFD2 |
| (<<) BIRC5 → MTHFD2 |
| Downstream (Children) |
|---|
| MTHFD2 → FABP5L2///FABP5L7///FABP5 (>>) |
| MTHFD2 → SKAP1 (>>) |
| MTHFD2 → LRP8 (>>) |
| MTHFD2 → PFKM (>>) |
| MTHFD2 → NDC80 (>>) |
| MTHFD2 → PTPLA (>>) |
| MTHFD2 → CHAC1 (>>) |
| MTHFD2 → CDH3 (>>) |
| MTHFD2 → ASNS (>>) |
| MTHFD2 → GDF11 (>>) |
| MTHFD2 → STC1 (>>) |
| MTHFD2 → CD3EAP (>>) |
| MTHFD2 → NT5DC2 (>>) |
| MTHFD2 → TMED3 (>>) |
| MTHFD2 → G6PD (>>) |
| MTHFD2 → RPS2 (>>) |
| MTHFD2 → PYCR1 (>>) |
